PURPOSE. To determine the indications for Ahmed glaucoma valve implantation by analyzing the duration and regimen of hypotensive therapy, and the configuration of previous interventions.METHODS. Retrospective evaluation of the duration and intensity of therapeutic treatment, and the configuration of laser and surgical procedures in a group of 139 patients (153 interventions) who underwent Ahmed glaucoma valve implantation in 2009–2011, and another group of 270 patients (272 interventions) who were treated in 2019–2010.RESULTS. The average age of candidates for implantation of the Ahmed valve increased from 63 y.o. in 2009–2011 to 70 y.o. in 2019–2020. The treatment preceding Ahmed valve implantation had extended in duration from 8.8±1.4 to 11.2±1.1 years leading to an increase in cumulative preservative toxicity from 9 293.8±968.6 to 10 038.1±888.9 µg. The main classes of intraocular pressure (IOP)-lowering drugs were prostaglandin analogues (75.4% in 2009–2011 and 77.1% in 2019–2020), carbonic anhydrase inhibitors (75.4% and 82.6%), and beta-blockers (57.4% and 61.1% accordingly). Laser trabeculoplasty was performed in only 11.8% and 28.7% of cases, respectively. Hypotensive filtering operations preceded valve implantation in 63.4% (2009–2011) and 80.5% of cases (2019–2020), while in the rest of patients the installation of the Ahmed device was the first surgical procedure. Despite treatment, the rate of glaucoma progression to an advanced stage increased from 62.1% in 2009–2011 to 82.7% in 2019–2020.CONCLUSION. With increase in the duration of conservative management of glaucoma its progression continues, while the increased preservative toxicity reduces the effectiveness of conjunctival surgery. In conclusion, earlier switch to surgical methods of IOP normalization involving the use of the Ahmed valve is advisable not only in secondary, but also in primary open-angle glaucoma treated conser-vatively for a long (over 7–8 years) period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.